Profound Medical (PROF) Share-based Compensation (2024 - 2026)
Profound Medical's (PROF) quarterly Share-based Compensation came in at $1.0 million in Q1 2026, up 5.97% year-on-year from $989000.0 in Q1 2025, and down 24.11% quarter-over-quarter from $1.4 million in Q4 2025.
Profound Medical (PROF) Share-based Compensation (2024 - 2026) Analysis & Trends
Profound Medical's Share-based Compensation history runs 3 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- On a quarterly basis, Share-based Compensation rose 5.97% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $5.5 million, a 126.67% increase from a year earlier, with the FY2025 full-year figure at $5.5 million, up 31.97% from the prior year.
- Share-based Compensation retreated to $1.0 million in Q1 2026 per PROF's latest filing, from $1.4 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $1.7 million in Q3 2025 and bottomed at $413000.0 in Q2 2024.
- The 3-year median for Share-based Compensation is $989000.0 (2025), against an average of $973777.8.
- Across the five-year window, Share-based Compensation surged 251.33% in 2025 and increased 5.97% in 2026, its largest moves.
- Year by year, Share-based Compensation stood at $442000.0 in 2024, then jumped by 212.44% to $1.4 million in 2025, then dropped by 24.11% to $1.0 million in 2026.
- Per Business Quant, the three latest PROF Share-based Compensation figures stand at $1.0 million (Q1 2026), $1.4 million (Q4 2025), and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profound Medical | 248.64 Mn | 198.34 Mn | 3.83 Mn | 1.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.05 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Dec 31, 2025 | 1.38 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 989,000.00 |
| Mar 31, 2025 | 989,000.00 |
| Dec 31, 2024 | 442,000.00 |
| Dec 31, 2024 | 442,000.00 |
| Sep 30, 2024 | 604,000.00 |
| Sep 30, 2024 | 604,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Jun 30, 2024 | 413,000.00 |
| Mar 31, 2024 | 767,000.00 |
| Mar 31, 2024 | 767,000.00 |